Expertise in
3
conditions

Danilo P. Villagelin

Campinas, SP, BR 
Expertise in
3
conditions
Campinas, SP, BR 

Overview

Danilo Villagelin practices practicing medicine in Campinas, Brazil.

Villagelin is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Graves Disease, Hyperthyroidism, Thyroid Eye Disease, and Hypothyroidism.

They are actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 2 clinical trials.

Locations

Campinas, SP, Brazil
Other Locations
Campinas, RS, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
View 1 Less Clinical Trial

23 Total Publications

Treatment outcomes in patients with relapsed Graves' disease.
Treatment outcomes in patients with relapsed Graves' disease.
Journal: Archives of endocrinology and metabolism
Published: May 15, 2026

Frequently Asked Questions about Danilo P. Villagelin

Is Danilo P. Villagelin a top-rated expert for Graves Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Danilo P. Villagelin is classified as an Distinguished expert for Graves Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Danilo P. Villagelin participate in research or clinical trials?

Yes. Danilo P. Villagelin has published 23 articles and abstracts on conditions like Graves Disease. You can view a list of Danilo P. Villagelin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Villagelin's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile